225 related articles for article (PubMed ID: 10071034)
1. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation.
Yamagami S; Tsuru T; Ohkawa T; Endo H; Isobe M
Transplantation; 1999 Feb; 67(4):600-4. PubMed ID: 10071034
[TBL] [Abstract][Full Text] [Related]
2. alpha/beta-T cell receptor-directed therapy in rat allograft recipients. Long-term survival of cardiac allografts after pretreatment with R73 mAb is associated with upregulation of Th2-type cytokines.
Heidecke CD; Hancock WW; Westerholt S; Sewczik T; Jakobs F; Zantl N; Varzaru A; Siegling A; Kurrle R; Deusch K; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(6):948-56. PubMed ID: 8623165
[TBL] [Abstract][Full Text] [Related]
3. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
[TBL] [Abstract][Full Text] [Related]
4. Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.
Heidecke CD; Zantl N; Maier S; Sewczik T; Westerholt S; Jakobs F; Westerholt A; Hancock WW; Kupiec-Weglinski JW
Transplantation; 1998 Nov; 66(10):1354-61. PubMed ID: 9846522
[TBL] [Abstract][Full Text] [Related]
5. alpha/beta-T cell receptor-directed therapy in rat cardiac allograft recipients. Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection.
Heidecke CD; Hancock WW; Jakobs F; Zantl N; Kurrle R; Westerholt S; Sewczik T; Deusch K; Kupiec-Weglinski J
Transplantation; 1995 Jan; 59(1):78-84. PubMed ID: 7839433
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cytokine profiles in corneal allograft with anti-adhesion therapy.
Yamagami S; Isobe M; Tsuru T
Transplantation; 2000 Apr; 69(8):1655-9. PubMed ID: 10836377
[TBL] [Abstract][Full Text] [Related]
7. Prolonged rat allograft survival induced by temporary elimination of alpha/beta T cells with monoclonal antibody.
Dufter C; Terness P; Post S; Thies J; Otto G; Meuer S; Opelz G
Transpl Int; 1994; 7 Suppl 1():S580-3. PubMed ID: 11271313
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
9. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.
Chen X; Zhao S; Tang X; Ge H; Liu P
Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190
[TBL] [Abstract][Full Text] [Related]
11. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506.
Yamagami S; Isobe M; Yamagami H; Hori J; Tsuru T
Transplantation; 1997 Jul; 64(1):42-8. PubMed ID: 9233699
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
14. Cytokine and chemokine expression kinetics after corneal transplantation.
King WJ; Comer RM; Hudde T; Larkin DF; George AJ
Transplantation; 2000 Oct; 70(8):1225-33. PubMed ID: 11063345
[TBL] [Abstract][Full Text] [Related]
15. Short-term T cell receptor directed immunotherapy induces organ specific peripheral tolerance in a strongly incompatible rat model.
Dufter C; Post S; Thies J; Otto G; Gaweco A; Meuer S; Terness P
Transpl Immunol; 1994 Dec; 2(4):278-84. PubMed ID: 7704537
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation.
Yamagami S; Kawashima H; Endo H; Tsuru T; Shibui H; Kagawa Y; Hori J; Yamagami H; Isobe M
Transplantation; 1998 Dec; 66(11):1504-10. PubMed ID: 9869092
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
[TBL] [Abstract][Full Text] [Related]
19. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune uveoretinitis by anti-alphabeta TCR monoclonal antibody.
Inoki T; Yamagami S; Sakai R; Isobe M; Tsuru T; Kawashima H
Jpn J Ophthalmol; 2002; 46(5):518-24. PubMed ID: 12457910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
